| Literature DB >> 35583203 |
Francesco Fiorentino1, Nicola Mautone1, Martina Menna1, Francesca D'Acunzo2, Antonello Mai1,3, Dante Rotili1.
Abstract
Sirtuins are NAD+-dependent protein lysine deacylase and mono-ADP ribosylases present in both prokaryotes and eukaryotes. The sirtuin family comprises seven isoforms in mammals, each possessing different subcellular localization and biological functions. Sirtuins have received increasing attention in the past two decades given their pivotal functions in a variety of biological contexts, including cytodifferentiation, transcriptional regulation, cell cycle progression, apoptosis, inflammation, metabolism, neurological and cardiovascular physiology and cancer. Consequently, modulation of sirtuin activity has been regarded as a promising therapeutic option for many pathologies. In this review, we provide an up-to-date overview of sirtuin biology and pharmacology. We examine the main features of the most relevant inhibitors and activators, analyzing their structure-activity relationships, applications in biology, and therapeutic potential.Entities:
Keywords: aging; cancer; drug discovery; epigenetics; metabolism; neurodegeneration; protein lysine deacylation; sirtuin modulators; sirtuins
Mesh:
Substances:
Year: 2022 PMID: 35583203 PMCID: PMC9185222 DOI: 10.4155/fmc-2022-0031
Source DB: PubMed Journal: Future Med Chem ISSN: 1756-8919 Impact factor: 4.767